Intellia Therapeutics to Present at November Healthcare Investor Conferences
Nov 02, 2017 20:30 pm UTC| Business
CAMBRIDGE, Mass., Nov. 02, 2017 -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, will present at the...
Nov 02, 2017 20:30 pm UTC| Business
EVANSVILLE, Ind., Nov. 02, 2017 -- Vectren Corporation (NYSE:VVC) today reported third quarter 2017 net income of $61.9 million, or $0.75 per share, compared to net income of $61.4 million, or $0.74 per share, in the...
Daseke, Inc. Announces Third Quarter Fiscal 2017 Earnings Conference Call and Webcast
Nov 02, 2017 20:30 pm UTC| Business
ADDISON, Texas, Nov. 02, 2017 -- Daseke, Inc. (NASDAQ:DSKE) (NASDAQ:DSKEW), a leading consolidator and the largest owner of flatbed and specialized transportation and logistics solutions in North America, announced...
QIWI to Announce Third Quarter 2017 Financial Results on November 16, 2017
Nov 02, 2017 20:30 pm UTC| Business
NICOSIA, Cyprus, Nov. 02, 2017 -- QIWI plc, (NASDAQ:QIWI) (MOEX:QIWI) (“QIWI” or the “Company”) today announced that it will host a conference call and webcast on Thursday, November 16, 2017 at 8:30 a.m. ET to review...
AquaBounty Technologies, Inc. Results for the quarter ended September 30, 2017
Nov 02, 2017 20:30 pm UTC| Business
MAYNARD, Mass., Nov. 02, 2017 -- AquaBounty Technologies, Inc. (NASDAQ:AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned...
Axovant Announces Second Fiscal Quarter Financial Results and Corporate Updates
Nov 02, 2017 20:30 pm UTC| Business
BASEL, Switzerland, Nov. 02, 2017 -- Axovant Sciences (Nasdaq:AXON) today announced financial results for its second fiscal quarter and first half ended September 30, 2017, and provided an update on its clinical...
Dova Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 9, 2017
Nov 02, 2017 20:30 pm UTC| Business
DURHAM, N.C., Nov. 02, 2017 -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet need,...